Cargando…
Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD)
Autores principales: | Hegvik, Tor-Arne, Husebye, Eystein S., Haavik, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918119/ https://www.ncbi.nlm.nih.gov/pubmed/23712861 http://dx.doi.org/10.1007/s00787-013-0429-3 |
Ejemplares similares
-
Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case–control study
por: Aarsland, Tore Ivar Malmei, et al.
Publicado: (2015) -
Sex differences in parent–offspring recurrence of attention‐deficit/hyperactivity disorder
por: Solberg, Berit S., et al.
Publicado: (2020) -
Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study
por: Hegvik, Tor-Arne, et al.
Publicado: (2017) -
Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment
por: Hegvik, Tor-Arne, et al.
Publicado: (2019) -
A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study
por: Hegvik, Tor-Arne, et al.
Publicado: (2016)